Pulse Biosciences, Inc. (PLSE) Misses Q2 EPS by 4c

Pulse Biosciences, Inc. (NASDAQ: PLSE) reported Q2 EPS of ($0.44), $0.04 worse than the analyst estimate of ($0.40). Revenue for the quarter came in at $265 thousand versus the consensus estimate of $439.67 thousand.

For earnings history and earnings-related data on Pulse Biosciences, Inc. (PLSE) click here.

You May Also Be Interested In

• FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
• Worthington Enterprises raises dividend 5%, adds board member
• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI